Supplemental Experimental Procedures
Neural Differentiation of hESCs Specificity of miR-9 knockdown; characterization of miR-9 expression in embryonic rat cortical NPCs and their progenies; effect of loss of miR-9 activity on cell proliferation but not cell survival of rat cortical NPCs. Immunostaining of hESC-derived neurospheres showed that migrating cells maintained their neural progenitor properties in vitro when miR-9 activity was knocked down. Loss of function experiments demonstrated that Stathmin mediated the effect of miR-9 on the proliferation of rat embryonic NPCs; a graphic summary for the roles of miR-9 in the neuronal differentiation of human stem cells. Tables   Table S1 . Related to Figure 6 List of predicted mRNA targets of miR-9 in Homo sapiens in the priority 1 group. Table S2 . Related to Figure 6 List of predicted mRNA targets of miR-9 in Homo sapiens in the priority 2 group. Table S3 . Related to Figure 6 Other selected predicted mRNA targets of miR-9 for expression correlation assay with miR-9. Table S4 . Related to Figure 6 Selected genes whose expression was down-regulated (1.5 fold) in early stage of hNPCs (isolated from neurospheres at 20 or 27 DIV) compared to the rosette stage (16 DIV)
Supplemental

Supplemental Experimental Procedures Neural Differentiation of hESCs
To initiate differentiation, hESC colonies were detached from the feeder layer with 0.5 μg/ml dispase (Invitrogen) and grown as aggregates or EBs in suspension for 4 days in hESC medium without FGF2. Cells were transferred to new culture dishes in the first 2 days to eliminate adherent MEFs. On day 5, EBs were transferred to flasks precoated with poly-L-ornithine/laminin (20 μg/ml) in neural induction medium (DMEM/F12/N2) consisting of 33% F12, 66% DMEM, 1X N2 supplement (25 mg/ml insulin, 50 mg/ml transferrin, 100 mM putrescine, 30 nM selenium chloride, and 20 nM progesterone), 1% nonessential amino acids solution, 10 ng/ml FGF2 (all from Invitrogen), and 2 mg/ml heparin (Sigma). EBs attached to the precoated plastic substrates in 2 days and were fed every other day. Cells migrated out from the EBs. After a few days in the neural induction medium, elongated cells appeared and formed rosettes. After 12 days, neuroepithelial cells in the rosettes were isolated from the surrounding cells with 0.2 mg/ml dispase. Rosette clumps were collected, triturated, and transferred to a flask for 2 to 3 h to allow non-neural cells to attach. The floating cells were transferred to a flask coated with poly-HEME (Sigma) to prevent cell attachment. At this stage, cells were transfected with Lipofectamine 2000 (Invitrogen) after additional mechanical dissociation into small clumps (10-50 cells). Neurospheres were formed 1 day after and were fed every other day with neural induction medium. Three-to four-week-old neurospheres were dissociated in Accutase solution (Sigma), and 200,000 cells were plated on glass coverslips coated with poly-D-lysine and laminin (BD). The cells were cultured in Neurobasal medium supplemented with 2% B27, 1% nonessential amino acids solution, 0.5 mM L-glutamine (all from Invitrogen), 1 μg/ml laminin (Sigma), 1 μM cyclic AMP (Sigma), 200 μM ascorbic acid (Sigma), 10 ng/ml BDNF (Invitrogen), and 10 ng/ml GDNF (R&D Systems) for 1-3 weeks. Half of the culture medium was changed every other day.
Analysis of miRNA and mRNA Expression
We used an endogenous control for real-time quantification of miRNA with TaqMan microRNA assays (Applied Biosystems) that shares similarities with miRNA, such as RNA stability and size. This assay was designed for the human small nucleolar RNA 
Cytotoxicity Analysis
hNPCs were transfected at 16 DIV at the transition from rosette to neurosphere stage.
One day later, the culture medium was changed, and same volume of fresh medium was added in all the samples. Twenty hours later, cultures were centrifuged to separate the medium from the neurospheres. LDH was measured in the medium and after lysis of the cells (intracellular LDH) to normalize for cell number. The medium was also changed three days after transfection and the same experiment performed twenty hours later to measure the percent of toxicity at 96h. Cytotoxicity was expressed as the percent of LDH released into the medium out of the total LDH activity (the sum of intracellular and released LDH activity). hNPCs mock transfected or transfected with a scrambled LNA probe served as controls.
WST1 proliferation assay
Rat cortical NPCs were seeded in 96-well plates at 10,000 cells/well and transfected the next day with control or anti-miR-9. Viable proliferating cells were detected at various times with the WST1 cell-proliferation assay (Roche Applied Science), and cell proliferation was measured according to the manufacturer's instructions. Four independent transfection experiments were performed, and the value for each time point was normalized to the value on day 1 after transfection.
In Vivo Migration Assays
Coronal forebrain slices (250 μm thick) were made from E14.5 C57BL/6 mice. Three slices from each brain were selected. This experiment was repeated three times (~10 embryos each). Neurospheres were transplanted 2 days after transfection with scrambled or anti-miR-9 LNA probes. These cells were also infected with the GFP-FUGW virus at 16 DIV of neuronal differentiation. Similar transduction efficiency was achieved by counting GFP-positive cells for both conditions (about 30%).
The migration of transplanted hNPCs in mouse brain slices was quantified in terms of the maximum distance. For each transplanted neurosphere, five cells that had migrated farthest from the neurosphere were selected and their average distance from the neurosphere was measured. The average of maximum distance from multiple transplanted neurospheres is presented in the figure 5D. Three independent experiments were performed with similar results. (A) Specific Inhibition of MiR-9 Function by the Anti-MiR-9 LNA Probe. Luciferase constructs containing miR-9 or miR-9* binding sites were cotransfected into HEK293 cells with or without pre-miR-9-2. Both miR-9 and miR-9* were produced from premiR-9-2. Anti-miR-9 did not interact with the miR-9* binding site in the luciferase 3'UTR but blocked the effect of pre-miR-9-2. In contrast, anti-miR-9 did not affect the ability of miR-9* to downregulate the expression of luciferase through the miR-9* binding site in the 3'UTR. These results demonstrate the specificity of the anti-miR-9 LNA probe. Values are mean ± s.e.m. Values are mean ± s.e.m. **P < 0 .01 vs. control.
(F-G) Rat NPCs proliferated at a slower rate in the absence of miR-9.
Rat cortical NPCs were transfected with scrambled control or anti-miR-9 and cultured in monolayer (F) or in suspension (G). Absorbance was measured after addition of the WST-1 cell proliferation reagent and normalized to 100 at 24 h post-transfection of the scrambled control or the anti-miR-9. The values are mean ± s.e.m. n = 4. **P < 0.01, ***P < 0.005. Immunostaining of hESC-derived neurospheres 6 days after transfection with anti-miR-9, which was 3 days after plating on the Matrigel matrix. heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 NM_006041 Selected genes for expression correlation assay with miR-9 are indicated in bold. Only targets in the Priority 2 group are listed. Same criteria as Priority 1 except that no destabilizing elements are present in one or more species. Table S3 . Other selected predicted mRNA targets of miR-9 for expression correlation assay with miR-9 -Related to Figure 6 Gene Gene Name mRNA_Accession Symbol SIRT1 sirtuin (silent mating type information regulation 2 NM_001142498 homolog) 1 (S. cerevisiae) ONECUT2 one cut homeobox 2 NM_004852 NR2E1 nuclear receptor subfamily 2, group E, member 1 NM_003269 FGF8 fibroblast growth factor 8 (androgen-induced) NM_006119, FGFR1 fibroblast growth factor receptor 1 NM_023105 Target prediction using microRNA.org identified SIRT1, ONECUT2 and NR2E1. FGF8 and FGFR1 are validated miR-9 targets in zebrafish. Table S4 . Selected genes whose expression was down-regulated (<-1.5 fold) in early stage of hNPCs (isolated from neurospheres 20 or 27 DIV) compared to the rosette stage (16 DIV) -Related to Figure 6 
Gene
Fold Changes Symbol (20 DIV vs. 16 DIV) (27 DIV16 vs. 16 DIV) hsa-miR-9
(mature miR-9) +20 +60
